Rankings
▼
Calendar
IRWD Q4 2019 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$603M
Q4 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$126M
-3.4% YoY
Gross Profit
$115M
91.3% margin
Operating Income
$50M
39.3% margin
Net Income
$48M
37.9% margin
EPS (Diluted)
$0.30
QoQ Revenue Growth
-3.7%
Cash Flow
Operating Cash Flow
$28M
Free Cash Flow
$25M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$403M
Total Liabilities
$496M
Stockholders' Equity
-$93M
Cash & Equivalents
$177M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$126M
$131M
-3.4%
Gross Profit
$115M
$109M
+5.5%
Operating Income
$50M
$6M
+727.2%
Net Income
$48M
-$15M
+408.9%
Revenue Segments
Collaborative Arrangements
$106M
81%
Active Pharmaceutical Ingredient
$21M
16%
Collaborative Arrangement Promotion Agreement
$2M
2%
Collaborative Arrangement Co Promotion Agreement
$1M
1%
Collaborative Arrangement Other Agreements
$229,000
0%
Geographic Segments
U
$102M
98%
North America
$603,000
1%
Canada And Mexico
$600,000
1%
Europe And Other
$510,000
0%
Europe
$500,000
0%
China Hong Kong And Macau
$227,000
0%
J
$88,000
0%
← FY 2019
All Quarters
Q1 2020 →